SynOx Therapeutics

📍 Dublin City, Ireland🗓 Founded 2020👥 25 employees💰 Last funded Jan 2025
Biotechnology Research🌐 synoxtherapeutics.com
Website LinkedIn
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Belgium
1
Netherlands
1
Frequently asked questions
Who invested in SynOx Therapeutics?
SynOx Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did SynOx Therapeutics last raise funding?
The most recent investment in SynOx Therapeutics recorded on gritt.io was in January 2025.
When was SynOx Therapeutics founded?
SynOx Therapeutics was founded in 2020.
What industry is SynOx Therapeutics in?
SynOx Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SynOx Therapeutics based?
SynOx Therapeutics is headquartered in Dublin City, Ireland.